Your browser doesn't support javascript.
loading
[Angiotensin II type 1 receptor autoantibody induces myocardial fibrosis by activating cardiac fibroblasts].
Hao, Wei-Wei; Zhang, Su-Li; Sun, Yan; Bai, Li-Na; Bian, Jing-Wei; Yu, Hai-Cun; Yin, Xiao-Chen; Wang, Peng-Li; Liu, Hui-Rong.
Affiliation
  • Hao WW; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Zhang SL; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Sun Y; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Bai LN; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Bian JW; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Yu HC; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Yin XC; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Wang PL; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Liu HR; Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Sheng Li Xue Bao ; 70(4): 343-353, 2018 Aug 25.
Article in Zh | MEDLINE | ID: mdl-30112559
ABSTRACT
Myocardial fibrosis (MF) is an important pathological process of cardiac remodeling in patients with heart failure; however its etiology has not been clear. It has been known that the angiotensin II type 1 receptor autoantibody (AT1-AA) is present in patients with heart failure, but it is unclear whether this antibody directly causes MF. In this study, we investigated the role of AT1-AA in MF and its effects on cardiac fibroblasts (CFs). The AT1-AA positive rat model was established by active immunization method, and the measurement of indexes were made in the 8th week after active immunity. The results of heart echocardiography showed that the cardiac systolic and diastolic functions of AT1-AA positive rats were impaired with reduced left ventricular wall thickness and enlarged heart chambers. HE staining results showed that the myocardial fibers were disorganized and ruptured, and Masson staining revealed that the area of collagen fibers around the myocardium and coronary arteries was significantly increased in AT1-AA positive group compared with that of the control group (P < 0.05). Moreover, primary CFs isolated from neonatal rats were cultured and treated with AT1-AA for 48 h. CCK-8 and immunofluorescence staining results showed that AT1-AA enhanced proliferation rate of CFs (P < 0.001), and Western blot results showed that AT1-AA significantly increased expressions of collagen I (Col I), Col III, matrix metalloproteinase-2 (MMP-2) and MMP-9 in CFs (all P < 0.05). Taken together, these results suggest that AT1-AA may induce MF and cardiac dysfunction via activating CFs.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptor, Angiotensin, Type 1 / Fibroblasts / Heart Failure / Myocardium Limits: Animals Language: Zh Journal: Sheng Li Xue Bao Year: 2018 Document type: Article Affiliation country: China
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Receptor, Angiotensin, Type 1 / Fibroblasts / Heart Failure / Myocardium Limits: Animals Language: Zh Journal: Sheng Li Xue Bao Year: 2018 Document type: Article Affiliation country: China